Moberg Pharma AB sell BiotechBee
Start price
13.05.24
/
70%
€2.37
Target price
31.05.26
€1.50
Performance (%)
-0.84%
End price
14.05.24
€2.35
Summary
This prediction ended on 14.05.24 with a price of €2.35. The SELL prediction by BiotechBee for Moberg Pharma AB closed nearly unchanged from the start price. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moberg Pharma AB | -1.235% | -1.235% | 14.883% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year